Daiko Matsuoka

3PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 31, 2024
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort.

Akihito Kawazoe, Noboru Yamamoto, Naotoshi Sugimoto

|Jan 05, 2024
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort.

Makoto Nishio, Shuji Murakami, Hisato Kawakami

|Jul 12, 2023
Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib.

Hanae Ida, Toshio Shimizu, Makoto Nishino

Pageof 1

Frequent Collaborators

3 joint publications

Taro Semba

3 joint publications

Takao Takase

3 joint publications

Noboru Yamamoto

3 joint publications

Yohei Otake